Skip to main content
HHS Logo U.S. Department of Health & Human Services Divider arrow NIH logo National Institutes of Health Alt desc
Anticancer cells on a laptop

NCATS, Karolinska Institutet Scientists Attack Cancer’s Defenses

Scientists from NCATS and Sweden’s Karolinska Institutet have developed a potential new approach to fighting cancer by breaking down a defense system used by cancer cells.

Work with Us

NCATS pre-clinical programs and resources focus on key obstacles and inefficiencies in the translational process, overcoming bottlenecks that slow the development of new treatments for patients.

Learn more about how to access NCATS programs and expertise.

Pre-Clinical Innovation

NCATS develops novel approaches to improve the process of joining basic science discoveries with initial testing of therapies in humans.

Find NCATS Programs & InitiativesAccess NCATS Expertise & Resources

Improving the Drug Development Process

Creating and testing innovative methods to improve and accelerate the drug development process and find new treatments for patients faster.

Repurposing Drugs

Discovering new uses for approved drugs to provide the quickest possible transition from bench to bedside.

Testing & Predictive Models

Developing better model systems for drug and toxicity testing.

Core Technologies

Using state-of-the-art resources to enable the ongoing operation of all NCATS translational research activities.

Inside the NCATS Laboratories

Anton Simeonov, Ph.D., and a high-throughput screening robot.

Take a video tour of our labs and see firsthand how our researchers work to get more treatments to more patients more quickly.